The neurofeedback systems market is gaining momentum as demand for non-invasive therapies for neurological disorders rises. With advancements in technology and growing adoption in healthcare, the market is set for steady growth.

The neurofeedback systems market was valued at USD 1.29 billion in 2024 and is projected to grow from USD 1.39 billion in 2025 to USD 2.51 billion by 2033, registering a strong CAGR of 7.70% during the forecast period.

📥 Download Sample Report

Neurofeedback is a biofeedback technique that helps people regulate brain activity through real-time feedback, often via visual or audio cues. Using electroencephalography (EEG), it monitors brain waves to encourage healthy neural patterns. The therapy is increasingly being used to treat conditions such as ADHD, PTSD, OCD, insomnia, epilepsy, and anxiety disorders. With more patients and healthcare providers turning to non-invasive and complementary therapies, the demand for neurofeedback systems is growing worldwide.

Key Market Growth Drivers

  • Rising prevalence of neurodegenerative diseases like Huntington's, dementia, and epilepsy

  • Technological advancements and product innovations, such as Bluetooth-enabled EEG devices

  • Growing incidence of brain dysfunctions linked to stress and insomnia

  • Increasing R&D investments and supportive healthcare initiatives

Challenges

Despite its potential, the market faces hurdles such as the high cost of devices, which can range from USD 7,000 for home systems to over USD 10,000 for professional ones. Additionally, rental training programs may cost USD 600–900 per month, limiting accessibility for some patients.

Market Opportunities

With expanding applications in healthcare, neurofeedback systems are gaining traction in areas such as anxiety and stress management. Initiatives like the European Commission’s Brain/Neural Computer Interaction Horizon 2020 project are expected to further accelerate innovation and adoption.

Regional Insights

  • North America leads the market, projected to grow at a CAGR of 7.9%. Strong healthcare infrastructure and high prevalence of insomnia and anxiety drive adoption.

  • Europe is the fastest-growing region, expected to generate USD 529 million by 2033 at a CAGR of 7.3%, supported by an aging population and rising dementia cases.

Type Insights

  • Frequency Neurofeedback dominates the market due to its ease of use and widespread application in treating ADHD, anxiety, and insomnia.

Application Insights

  • ADHD is the largest application segment, advancing at a CAGR of 8.2%, followed by insomnia, which holds the second-largest share.

Key Players in the Neurofeedback Systems Market

  • Brainmaster Technologies Inc.

  • BEE Medic

  • Neurobit Systems

  • NeuroCare Group GmbH

  • Thought Technology Ltd

  • Mind Media BV

  • Wearable Sensing

  • Mitsar Co. Ltd

  • Myndlif

Recent Developments

  • 2022: NeuroCare Group GmbH opened its first UK clinic in London, offering neurofeedback, rTMS therapy, psychotherapy, and health coaching.

  • 2019: Narbis launched its smart glasses, integrating NASA algorithms to improve concentration and reduce drowsiness.

Conclusion

The neurofeedback systems market is set for sustained growth, driven by rising neurological disorders, technological innovations, and growing healthcare applications. While high costs remain a restraint, expanding opportunities in mental health and neurology are expected to fuel adoption in the years ahead.

About Us:

Straits Research is a leading global market intelligence and consulting firm, dedicated to delivering actionable insights and in-depth analysis across a wide range of industries. Our mission is to empower organizations, investors, and decision-makers with reliable data, strategic guidance, and forward-looking perspectives to help them thrive in a rapidly evolving business landscape.

Contact Us:

Email: sales@straitsresearch.com
Tel: +1 646 905 0080 (U.S.), +44 203 695 0070 (U.K.)
Website: https://straitsresearch.com/